In a special report, Reuters examines the case of Timothy Ray Brown, who was cured of HIV and leukemia after undergoing "a bone marrow transplant using cells from a donor with a rare genetic mutation, known as CCR5 delta 32," which researchers knew conveyed resistance to HIV infection. Also known as "the Berlin patient," Brown's case "has injected new energy into a field where people for years believed talk of a cure was irresponsible," the news service reports (Kelland, 6/1).
The June 6 issue of New York Magazine also includes a feature on Brown's case. "What cured Timothy Brown is obviously not a cure for the rest of the world. But it is proof of concept," the magazine writes (Rosenberg, 5/29).
Back to other news for June 2011
This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.